Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Factors associated with benign multiple sclerosis in the New York State MS Consortium (NYSMSC).

Zivadinov R, Cookfair DL, Krupp L, Miller AE, Lava N, Coyle PK, Goodman AD, Jubelt B, Lenihan M, Herbert J, Gottesman M, Snyder DH, Apatoff BR, Teter BE, Perel AB, Munschauer F, Weinstock-Guttman B.

BMC Neurol. 2016 Jul 15;16:102. doi: 10.1186/s12883-016-0623-2.

2.

Relationship between Inflammation and Aspirin and Clopidogrel Antiplatelet Responses in Acute Ischemic Stroke.

Sternberg Z, Chichelli T, Sternberg D, Sawyer R, Ching M, Janicke D, Ambrus JL, Yu J, Munschauer F.

J Stroke Cerebrovasc Dis. 2016 Feb;25(2):327-34. doi: 10.1016/j.jstrokecerebrovasdis.2015.10.001. Epub 2015 Nov 12.

PMID:
26586373
3.

Quantitative and qualitative pleiotropic differences between Simvastatin single and Vytorin combination therapy in hypercholesterolemic subjects.

Sternberg Z, Chichelli T, Sternberg D, Hojnacki D, Drake A, Liu S, Hu Q, Munschauer F.

Atherosclerosis. 2013 Dec;231(2):411-20. doi: 10.1016/j.atherosclerosis.2013.09.031. Epub 2013 Oct 16.

PMID:
24267260
4.

Flow cytometry and gene expression profiling of immune cells of the carotid plaque and peripheral blood.

Sternberg Z, Ghanim H, Gillotti KM, Tario JD Jr, Munschauer F, Curl R, Noor S, Yu J, Ambrus JL Sr, Wallace P, Dandona P.

Atherosclerosis. 2013 Aug;229(2):338-47. doi: 10.1016/j.atherosclerosis.2013.04.035. Epub 2013 May 14.

PMID:
23880185
5.

Lp-PLA2: inflammatory biomarker of vascular risk in multiple sclerosis.

Sternberg Z, Drake A, Sternberg DS, Benedict RH, Li F, Hojnacki D, Weinstock-Guttmann B, Munschauer FE.

J Clin Immunol. 2012 Jun;32(3):497-504. doi: 10.1007/s10875-011-9642-3. Epub 2012 Jan 13.

PMID:
22246459
6.

Clopidogrel responsiveness in stroke patients on a chronic aspirin regimen.

Sternberg Z, Ching M, Sawyer RN, Chichelli T, Li F, Janicke D, Radovic V, Mehta B, Farooq O, Munschauer FE.

J Stroke Cerebrovasc Dis. 2013 Aug;22(6):725-32. doi: 10.1016/j.jstrokecerebrovasdis.2011.11.009. Epub 2011 Dec 28.

PMID:
22209644
7.

Acamprosate modulates experimental autoimmune encephalomyelitis.

Sternberg Z, Cesario A, Rittenhouse-Olson K, Sobel RA, Leung YK, Pankewycz O, Zhu B, Whitcomb T, Sternberg DS, Munschauer FE.

Inflammopharmacology. 2012 Feb;20(1):39-48. doi: 10.1007/s10787-011-0097-1. Epub 2011 Nov 17. Erratum in: Inflammopharmacology. 2012 Feb;20(1):49. Leung, Yi-Kan [added].

PMID:
22090150
8.

Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis.

Phillips JT, Giovannoni G, Lublin FD, O'Connor PW, Polman CH, Willoughby E, Aschenbach W, Pace A, Hyde R, Munschauer FE.

Mult Scler. 2011 Aug;17(8):970-9. doi: 10.1177/1352458511399611. Epub 2011 Mar 18.

PMID:
21421809
9.

AGE-RAGE in multiple sclerosis brain.

Sternberg Z, Ostrow P, Vaughan M, Chichelli T, Munschauer F.

Immunol Invest. 2011;40(2):197-205. doi: 10.3109/08820139.2010.532267. Epub 2010 Nov 16.

PMID:
21080832
10.

Diagnostic potential of plasma carboxymethyllysine and carboxyethyllysine in multiple sclerosis.

Sternberg Z, Hennies C, Sternberg D, Wang P, Kinkel P, Hojnacki D, Weinstock-Guttmann B, Munschauer F.

J Neuroinflammation. 2010 Oct 29;7:72. doi: 10.1186/1742-2094-7-72.

11.

Plasma pentosidine: a potential biomarker in the management of multiple sclerosis.

Sternberg Z, Hennies C, Sternberg D, Bistulfi GL, Kazim L, Benedict RH, Chadha K, Leung C, Weinstock-Guttman B, Munschauer F.

Mult Scler. 2011 Feb;17(2):157-63. doi: 10.1177/1352458510384123. Epub 2010 Oct 21.

PMID:
20965962
12.

Gender effects on intramuscular interferon beta-1a in relapsing-remitting multiple sclerosis: analysis of 1406 patients.

Rudick RA, Kappos L, Kinkel R, Clanet M, Phillips JT, Herndon RM, Sandrock AW, Munschauer FE 3rd.

Mult Scler. 2011 Mar;17(3):353-60. doi: 10.1177/1352458510384605. Epub 2010 Oct 21.

PMID:
20965959
13.

Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline.

Morrow SA, Drake A, Zivadinov R, Munschauer F, Weinstock-Guttman B, Benedict RH.

Clin Neuropsychol. 2010 Oct;24(7):1131-45. doi: 10.1080/13854046.2010.511272. Epub 2010 Sep 8.

PMID:
20830649
14.

Rapid disease course in African Americans with multiple sclerosis.

Kister I, Chamot E, Bacon JH, Niewczyk PM, De Guzman RA, Apatoff B, Coyle P, Goodman AD, Gottesman M, Granger C, Jubelt B, Krupp L, Lenihan M, Lublin F, Mihai C, Miller A, Munschauer FE 3rd, Perel AB, Teter BE, Weinstock-Guttman B, Zivadinov R, Herbert J.

Neurology. 2010 Jul 20;75(3):217-23. doi: 10.1212/WNL.0b013e3181e8e72a.

PMID:
20644149
15.

Increased tissue damage and lesion volumes in African Americans with multiple sclerosis.

Weinstock-Guttman B, Ramanathan M, Hashmi K, Abdelrahman N, Hojnacki D, Dwyer MG, Hussein S, Bergsland N, Munschauer FE, Zivadinov R.

Neurology. 2010 Feb 16;74(7):538-44. doi: 10.1212/WNL.0b013e3181cff6fb. Epub 2010 Jan 20.

PMID:
20089944
16.

Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test.

Drake AS, Weinstock-Guttman B, Morrow SA, Hojnacki D, Munschauer FE, Benedict RH.

Mult Scler. 2010 Feb;16(2):228-37. doi: 10.1177/1352458509354552. Epub 2009 Dec 22.

PMID:
20028710
17.

Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-beta.

Sternberg Z, Chadha K, Lieberman A, Drake A, Hojnacki D, Weinstock-Guttman B, Munschauer F.

J Neuroinflammation. 2009 Oct 13;6:28. doi: 10.1186/1742-2094-6-28.

18.

Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis.

Morrow SA, Weinstock-Guttman B, Munschauer FE, Hojnacki D, Benedict RH.

Mult Scler. 2009 Aug;15(8):998-1005. doi: 10.1177/1352458509106213.

PMID:
19667024
19.

MRI characteristics of patients with antiphospholipid syndrome and multiple sclerosis.

Stosic M, Ambrus J, Garg N, Weinstock-Guttman B, Ramanathan M, Kalman B, Minagar A, Munschauer FE, Galey TM, Hussein S, Bakshi R, Zivadinov R.

J Neurol. 2010 Jan;257(1):63-71. doi: 10.1007/s00415-009-5264-6. Epub 2009 Jul 26.

PMID:
19633967
20.

Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS.

Strober L, Englert J, Munschauer F, Weinstock-Guttman B, Rao S, Benedict RH.

Mult Scler. 2009 Sep;15(9):1077-84. doi: 10.1177/1352458509106615. Epub 2009 Jun 25.

PMID:
19556311
21.

The effects of L-amphetamine sulfate on cognition in MS patients: results of a randomized controlled trial.

Morrow SA, Kaushik T, Zarevics P, Erlanger D, Bear MF, Munschauer FE, Benedict RH.

J Neurol. 2009 Jul;256(7):1095-102. doi: 10.1007/s00415-009-5074-x. Epub 2009 Mar 5.

PMID:
19263186
22.

Gender-related differences in MS: a study of conventional and nonconventional MRI measures.

Antulov R, Weinstock-Guttman B, Cox JL, Hussein S, Durfee J, Caiola C, Dwyer MG, Bergsland N, Abdelrahman N, Stosic M, Hojnacki D, Munschauer FE, Miletic D, Zivadinov R.

Mult Scler. 2009 Mar;15(3):345-54. doi: 10.1177/1352458508099479. Epub 2008 Nov 21.

PMID:
19028830
23.

Genomic effects of once-weekly, intramuscular interferon-beta1a treatment after the first dose and on chronic dosing: Relationships to 5-year clinical outcomes in multiple sclerosis patients.

Weinstock-Guttman B, Bhasi K, Badgett D, Tamaño-Blanco M, Minhas M, Feichter J, Patrick K, Munschauer F, Bakshi R, Ramanathan M.

J Neuroimmunol. 2008 Dec 15;205(1-2):113-25. doi: 10.1016/j.jneuroim.2008.09.004. Epub 2008 Oct 23.

PMID:
18950872
24.

Quercetin and interferon-beta modulate immune response(s) in peripheral blood mononuclear cells isolated from multiple sclerosis patients.

Sternberg Z, Chadha K, Lieberman A, Hojnacki D, Drake A, Zamboni P, Rocco P, Grazioli E, Weinstock-Guttman B, Munschauer F.

J Neuroimmunol. 2008 Dec 15;205(1-2):142-7. doi: 10.1016/j.jneuroim.2008.09.008. Epub 2008 Oct 15.

PMID:
18926575
25.

Clinical efficacy, effects on MRI and tolerability of weekly intramuscular interferon-beta-1a in patients with MS and CIS.

Zivadinov R, Munschauer FE, Ramanathan M, Benedict RH, Weinstock-Guttman B.

Drugs Today (Barc). 2008 Aug;44(8):601-13. doi: 10.1358/dot.2008.44.8.1242250. Review.

PMID:
18846271
26.

Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy.

Benedict RH, Ramasamy D, Munschauer F, Weinstock-Guttman B, Zivadinov R.

J Neurol Neurosurg Psychiatry. 2009 Feb;80(2):201-6. doi: 10.1136/jnnp.2008.148403. Epub 2008 Oct 1.

PMID:
18829629
27.

Application of hidden Markov random field approach for quantification of perfusion/diffusion mismatch in acute ischemic stroke.

Dwyer MG, Bergsland N, Saluste E, Sharma J, Jaisani Z, Durfee J, Abdelrahman N, Minagar A, Hoque R, Munschauer FE 3rd, Zivadinov R.

Neurol Res. 2008 Oct;30(8):827-34. doi: 10.1179/174313208X340987.

PMID:
18826809
28.

Use of perfusion- and diffusion-weighted imaging in differential diagnosis of acute and chronic ischemic stroke and multiple sclerosis.

Zivadinov R, Bergsland N, Stosic M, Sharma J, Nussenbaum F, Durfee J, Hani N, Abdelrahman N, Jaisani Z, Minagar A, Hoque R, Munschauer FE 3rd, Dwyer MG.

Neurol Res. 2008 Oct;30(8):816-26. doi: 10.1179/174313208X341003.

PMID:
18826808
29.

Cortical atrophy and personality in multiple sclerosis.

Benedict RH, Hussein S, Englert J, Dwyer MG, Abdelrahman N, Cox JL, Munschauer FE, Weinstock-Guttman B, Zivadinov R.

Neuropsychology. 2008 Jul;22(4):432-41. doi: 10.1037/0894-4105.22.4.432.

PMID:
18590355
30.

Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire.

Benedict RH, Duquin JA, Jurgensen S, Rudick RA, Feitcher J, Munschauer FE, Panzara MA, Weinstock-Guttman B.

Mult Scler. 2008 Aug;14(7):940-6. doi: 10.1177/1352458508090923. Epub 2008 Jun 23.

PMID:
18573822
31.

Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis optica.

Weinstock-Guttman B, Miller C, Yeh E, Stosic M, Umhauer M, Batra N, Munschauer F, Zivadinov R, Ramanathan M.

Mult Scler. 2008 Sep;14(8):1061-7. doi: 10.1177/1352458508092811. Epub 2008 Jun 23.

PMID:
18573816
32.

Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severity.

Sternberg Z, Weinstock-Guttman B, Hojnacki D, Zamboni P, Zivadinov R, Chadha K, Lieberman A, Kazim L, Drake A, Rocco P, Grazioli E, Munschauer F.

Mult Scler. 2008 Jul;14(6):759-63. doi: 10.1177/1352458507088105. Epub 2008 May 27.

PMID:
18505774
33.

Effects of l-amphetamine sulfate on cognitive function in multiple sclerosis patients.

Benedict RH, Munschauer F, Zarevics P, Erlanger D, Rowe V, Feaster T, Carpenter RL.

J Neurol. 2008 Jun;255(6):848-52. doi: 10.1007/s00415-008-0760-7. Epub 2008 May 16.

PMID:
18481035
34.

A community education program on atrial fibrillation: implications of pulse self-examination on awareness and behavior.

Munschauer FE 3rd, Sohocki D, Smith Carrow S, Priore RL.

J Stroke Cerebrovasc Dis. 2004 Sep-Oct;13(5):208-13.

PMID:
17903977
35.

Screening for atrial fibrillation in the community: a multicenter validation trial.

Munschauer FE, Hens MM, Priore RL, Stolarski E, Buffamonte S, Carlin A, Wechsler L, Massaro L, Barch C, Hughes R, Anderson A, Sung G, Baker S, Limon S.

J Stroke Cerebrovasc Dis. 1999 Mar-Apr;8(2):99-103.

PMID:
17895149
36.

Diffusion-weighted imaging predicts cognitive impairment in multiple sclerosis.

Benedict RH, Bruce J, Dwyer MG, Weinstock-Guttman B, Tjoa C, Tavazzi E, Munschauer FE, Zivadinov R.

Mult Scler. 2007 Jul;13(6):722-30. Epub 2007 Mar 15.

PMID:
17613599
37.

Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis.

Tekok-Kilic A, Benedict RH, Weinstock-Guttman B, Dwyer MG, Carone D, Srinivasaraghavan B, Yella V, Abdelrahman N, Munschauer F, Bakshi R, Zivadinov R.

Neuroimage. 2007 Jul 15;36(4):1294-300. Epub 2007 Apr 18.

PMID:
17524670
38.

Clinical and MRI correlates of autoreactive antibodies in multiple sclerosis patients.

Garg N, Zivadinov R, Ramanathan M, Vasiliu I, Locke J, Watts K, Lema J, Rajeswary J, Munschauer FE, Ambrus J Jr, Weinstock-Guttman B.

J Neuroimmunol. 2007 Jul;187(1-2):159-65. Epub 2007 May 18.

PMID:
17512610
39.

Quantitative diffusion weighted imaging measures in patients with multiple sclerosis.

Tavazzi E, Dwyer MG, Weinstock-Guttman B, Lema J, Bastianello S, Bergamaschi R, Cosi V, Benedict RH, Munschauer FE 3rd, Zivadinov R.

Neuroimage. 2007 Jul 1;36(3):746-54. Epub 2007 Apr 10.

PMID:
17498974
40.

Validity of the Wisconsin Card Sorting and Delis-Kaplan Executive Function System (DKEFS) Sorting Tests in multiple sclerosis.

Parmenter BA, Zivadinov R, Kerenyi L, Gavett R, Weinstock-Guttman B, Dwyer MG, Garg N, Munschauer F, Benedict RH.

J Clin Exp Neuropsychol. 2007 Feb;29(2):215-23.

PMID:
17365256
41.

Screening for cognitive impairment in multiple sclerosis using the Symbol digit Modalities Test.

Parmenter BA, Weinstock-Guttman B, Garg N, Munschauer F, Benedict RH.

Mult Scler. 2007 Jan;13(1):52-7.

PMID:
17294611
42.

Interferon inhibitory activity in patients with multiple sclerosis.

Chadha K, Weinstock-Guttman B, Zivadinov R, Bhasi K, Muhitch J, Feichter J, Tamaño-Blanco M, Abdelrahman N, Ambrus J Sr, Munschauer F, Ramanathan M.

Arch Neurol. 2006 Nov;63(11):1579-84.

PMID:
17101826
43.

Faith-placed cardiovascular health promotion: a framework for contextual and organizational factors underlying program success.

Sternberg Z, Munschauer FE 3rd, Carrow SS, Sternberg E.

Health Educ Res. 2007 Oct;22(5):619-29. Epub 2006 Oct 23.

PMID:
17060351
44.

Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).

Benedict RH, Cookfair D, Gavett R, Gunther M, Munschauer F, Garg N, Weinstock-Guttman B.

J Int Neuropsychol Soc. 2006 Jul;12(4):549-58.

PMID:
16981607
45.

Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis.

Benedict RH, Bruce JM, Dwyer MG, Abdelrahman N, Hussein S, Weinstock-Guttman B, Garg N, Munschauer F, Zivadinov R.

Arch Neurol. 2006 Sep;63(9):1301-6.

PMID:
16966509
46.

Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis.

Brass SD, Benedict RH, Weinstock-Guttman B, Munschauer F, Bakshi R.

Mult Scler. 2006 Aug;12(4):437-44.

PMID:
16900757
47.

A 47-year-old man with sudden onset of blindness, pleocytosis, and temporary hearing loss. Vogt-Koyanagi-Harada syndrome (Uveomeningoencephalitic syndrome).

Khoury T, Gonzalez-Fernandez F, Munschauer FE 3rd, Ostrow P.

Arch Pathol Lab Med. 2006 Jul;130(7):1070-2.

PMID:
16831039
48.

Dynamics of interferon-beta modulated mRNA biomarkers in multiple sclerosis patients with anti-interferon-beta neutralizing antibodies.

Santos R, Weinstock-Guttman B, Tamaño-Blanco M, Badgett D, Zivadinov R, Justinger T, Munschauer F 3rd, Ramanathan M.

J Neuroimmunol. 2006 Jul;176(1-2):125-33. Epub 2006 May 15.

PMID:
16698090
49.

Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy.

Garg R, Chaudhuri A, Munschauer F, Dandona P.

Stroke. 2006 Jan;37(1):267-73. Epub 2005 Nov 23. Review.

PMID:
16306459
50.

Geographical variation of cerebrovascular disease in New York State: the correlation with income.

Han D, Carrow SS, Rogerson PA, Munschauer FE.

Int J Health Geogr. 2005 Oct 21;4:25.

Supplemental Content

Loading ...
Support Center